Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
Jul 1, 2026, 4:00 PM EST
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $24.27 thousand as of July 2, 2026. Its market cap has decreased by -98.54% in one year.
Market Cap
24.27K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 19, 2015, Panbela Therapeutics's market cap has decreased from 89.28M to 24.27K, a decrease of -99.97%. That is a compound annual growth rate of -53.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 24.27K | 2,399.90% |
| Dec 31, 2025 | 971.00 | -99.95% |
| Dec 31, 2024 | 1.84M | -70.55% |
| Dec 29, 2023 | 6.27M | 109.12% |
| Dec 30, 2022 | 3.00M | -87.09% |
| Dec 31, 2021 | 23.21M | -32.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Itoco | 42.82K |
| Hemagen Diagnostics | 40.30K |
| Scopus BioPharma | 25.25K |
| Ocean Biomedical | 23.24K |
| Health Sciences Group | 20.51K |
| NanoLogix | 16.29K |
| Regenicin | 15.35K |
| Virpax Pharmaceuticals | 13.79K |